- Work
- Life Sciences
Peer-reviewed science, finally measurable.
Engraffo gives STM publishers and the life-science brands that license their work a single place to host premium content, deliver it through controlled links, and see how it performs. Logicbomb Media engineered and designed the entire platform on Nuxt and Laravel.
Flying blind on expensive science.
Engraffo was born from a real gap. As scientific publishing moved from physical reprints to digital “ePrints,” the life-science companies licensing that content were flying blind — they had little visibility into whether the expensive, peer-reviewed material they put in front of physicians was actually being read.
Engraffo closed that gap, pairing modern digital delivery with the performance analytics the category never had: who viewed, how long they read, and how engagement tracked against the goal.
One place to host, deliver, and measure.
Engraffo operates as a multi-sided platform: publishers on one side, pharmaceutical and life-science customers on the other, and the medical-communications agencies that work between them — all serving the same end audience of healthcare professionals.
A publisher uploads as many assets as they like and composes a custom, branded landing page for each publication — most often presented as a polished PDF flipbook — then controls exactly how it behaves. Layered on top is the analytics engine that gives both publishers and their customers a clear, shared view of content performance.
Controlled delivery
Every publication gets a publisher-composed, branded landing page with exact behavioral controls: download permissions, view counts, time windows, and access limits. Premium content moves through controlled links — never an open URL.
Built-in compliance
Because the audience is healthcare professionals, HCP verification is built in — capturing NPI and medical-license details — with configurable Sunshine Act data collection for the transparency rules pharmaceutical engagement demands.
Logicbomb Media engineered and designed the entire platform on Nuxt and Laravel — content hosting, controlled link delivery, HCP verification, and the analytics engine that gives publishers and their customers a shared view of performance. Ibis Labs owns the business; LBM built the product from the ground up.
A category standard.
Over five years, Engraffo has hosted more than 640 scientific publications and delivered tens of thousands of verified healthcare-professional reads — and adoption is accelerating, with 2025 its strongest year yet and 2026 on pace to surpass it.
The platform is trusted across the upper tier of global scientific publishing and used by many of the world's largest pharmaceutical companies — a leading position in a specialized, demanding field that LBM built for the client from the ground up.
Purpose-built platforms start with one conversation.
Purpose-built platforms start with one conversation.